CGEM – cullinan oncology, inc. (US:AMEX)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

CGEM

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

3/5

04:31 pm

cgem

Form 144 Cullinan Therapeutics, Filed by: Michaelson Jennifer

Low Report

Form 144 Cullinan Therapeutics, Filed by: Michaelson Jennifer

Report

3/4

03:17 pm

cgem

Form SCHEDULE 13G Cullinan Therapeutics, Filed by: Kynam Capital Management, LP

Low Report

Form SCHEDULE 13G Cullinan Therapeutics, Filed by: Kynam Capital Management, LP

Report

2/26

05:05 pm

cgem

Form 4 Cullinan Therapeutics, For: Feb 25 Filed by: Michaelson Jennifer

Low Report

Form 4 Cullinan Therapeutics, For: Feb 25 Filed by: Michaelson Jennifer

Report

2/25

05:00 pm

cgem

Form 4 Cullinan Therapeutics, For: Feb 24 Filed by: SUMER JACQUELYN L

Medium Report

Form 4 Cullinan Therapeutics, For: Feb 24 Filed by: SUMER JACQUELYN L

Report

2/25

05:00 pm

cgem

Form 4 Cullinan Therapeutics, For: Feb 23 Filed by: Michaelson Jennifer

Medium Report

Form 4 Cullinan Therapeutics, For: Feb 23 Filed by: Michaelson Jennifer

Report

2/25

05:00 pm

cgem

Form 4 Cullinan Therapeutics, For: Feb 24 Filed by: AHMED NADIM

Medium Report

Form 4 Cullinan Therapeutics, For: Feb 24 Filed by: AHMED NADIM

Report

2/25

05:00 pm

cgem

Form 4 Cullinan Therapeutics, For: Feb 24 Filed by: Jones Jeffrey Alan

Medium Report

Form 4 Cullinan Therapeutics, For: Feb 24 Filed by: Jones Jeffrey Alan

Report

2/25

04:34 pm

cgem

Form 144 Cullinan Therapeutics, Filed by: Michaelson Jennifer

Medium Report

Form 144 Cullinan Therapeutics, Filed by: Michaelson Jennifer

Report

2/23

05:00 pm

cgem

Form 4 Cullinan Therapeutics, For: Feb 20 Filed by: SUMER JACQUELYN L

Low Report

Form 4 Cullinan Therapeutics, For: Feb 20 Filed by: SUMER JACQUELYN L

Report

2/23

05:00 pm

cgem

Form 4 Cullinan Therapeutics, For: Feb 20 Filed by: AHMED NADIM

Low Report

Form 4 Cullinan Therapeutics, For: Feb 20 Filed by: AHMED NADIM

Report

2/23

05:00 pm

cgem

Form 4 Cullinan Therapeutics, For: Feb 20 Filed by: Michaelson Jennifer

Low Report

Form 4 Cullinan Therapeutics, For: Feb 20 Filed by: Michaelson Jennifer

Report

2/23

05:00 pm

cgem

Form 4 Cullinan Therapeutics, For: Feb 20 Filed by: Fenton Mary Kay

Low Report

Form 4 Cullinan Therapeutics, For: Feb 20 Filed by: Fenton Mary Kay

Report

2/23

05:00 pm

cgem

Form 4 Cullinan Therapeutics, For: Feb 20 Filed by: Jones Jeffrey Alan

Low Report

Form 4 Cullinan Therapeutics, For: Feb 20 Filed by: Jones Jeffrey Alan

Report

2/23

04:31 pm

cgem

Form 144 Cullinan Therapeutics, Filed by: Michaelson Jennifer

Low Report

Form 144 Cullinan Therapeutics, Filed by: Michaelson Jennifer

Report

2/20

04:28 pm

cgem

Form 144 Cullinan Therapeutics, Filed by: Michaelson Jennifer

Low Report

Form 144 Cullinan Therapeutics, Filed by: Michaelson Jennifer

Report

2/19

05:00 pm

cgem

Form 4 Cullinan Therapeutics, For: Feb 18 Filed by: Fenton Mary Kay

Low Report

Form 4 Cullinan Therapeutics, For: Feb 18 Filed by: Fenton Mary Kay

Report

2/19

05:00 pm

cgem

Form 4 Cullinan Therapeutics, For: Feb 18 Filed by: SUMER JACQUELYN L

Low Report

Form 4 Cullinan Therapeutics, For: Feb 18 Filed by: SUMER JACQUELYN L

Report

2/19

05:00 pm

cgem

Form 4 Cullinan Therapeutics, For: Feb 18 Filed by: Michaelson Jennifer

Low Report

Form 4 Cullinan Therapeutics, For: Feb 18 Filed by: Michaelson Jennifer

Report

2/19

05:00 pm

cgem

Form 4 Cullinan Therapeutics, For: Feb 18 Filed by: Jones Jeffrey Alan

Low Report

Form 4 Cullinan Therapeutics, For: Feb 18 Filed by: Jones Jeffrey Alan

Report

2/19

05:00 pm

cgem

Form 4 Cullinan Therapeutics, For: Feb 18 Filed by: Savill Corrine

Low Report

Form 4 Cullinan Therapeutics, For: Feb 18 Filed by: Savill Corrine

Report

2/19

05:00 pm

cgem

Form 4 Cullinan Therapeutics, For: Feb 18 Filed by: AHMED NADIM

Low Report

Form 4 Cullinan Therapeutics, For: Feb 18 Filed by: AHMED NADIM

Report

2/17

04:11 pm

cgem

Form SCHEDULE 13G/A Cullinan Therapeutics, Filed by: BIOTECHNOLOGY VALUE FUND L P

Low Report

Form SCHEDULE 13G/A Cullinan Therapeutics, Filed by: BIOTECHNOLOGY VALUE FUND L P

Report

2/13

05:01 pm

cgem

Form 4 Cullinan Therapeutics, For: Feb 12 Filed by: Michaelson Jennifer

Medium Report

Form 4 Cullinan Therapeutics, For: Feb 12 Filed by: Michaelson Jennifer

Report

1/30

01:27 pm

cgem

Form SCHEDULE 13G Cullinan Therapeutics, Filed by: VANGUARD GROUP INC

Low Report

Form SCHEDULE 13G Cullinan Therapeutics, Filed by: VANGUARD GROUP INC

Report

1/23

05:00 pm

cgem

Form 4 Cullinan Therapeutics, For: Jan 22 Filed by: Michaelson Jennifer

Low Report

Form 4 Cullinan Therapeutics, For: Jan 22 Filed by: Michaelson Jennifer

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.